Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
NASDAQ:TNDM
TNDM Stock Chart & Stats
$15.21
-$0.45(-1.21%)
At close: 4:00 PM EST
$15.21
-$0.45(-1.21%)
Day’s Range― - ―
52-Week Range$9.98 - $38.28
Previous CloseN/A
Volume336.73K
Average Volume (3M)1.73M
Market Cap
$1.03B
Enterprise Value$1.38B
Total Cash (Recent Filing)$315.36M
Total Debt (Recent Filing)$449.01M
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Nov 06, 2025EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.48
Shares Outstanding67,569,470
10 Day Avg. Volume1,482,554
30 Day Avg. Volume1,725,210
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.35
Enterprise Value/Revenue1.23
Enterprise Value/Gross Profit2.63
Enterprise Value/Ebitda-7.79
Forecast
1Y Price Target
$18.95Price Target Upside24.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
EPS Forecast (FY)-2.09
Revenue Forecast (FY)$997.96M
Bulls Say, Bears Say
Bulls Say
CMS ProposalThe CMS proposal could drive further adoption by increasing the number of patients interested in pump therapy and decreasing out-of-pocket costs.
Pharmacy ExpansionTandem sees the ongoing push into pharmacy as a major driver for the business on higher revenue and profitability per unit while simultaneously enabling lower co-pays for patients.
Product LaunchesNew product catalysts on the horizon: Mobi Tubeless is expected to launch in 2026, which should allow Tandem to compete more effectively against other patch offerings while retaining the same core Mobi pump to support margin expansion.
Bears Say
Growth ExpectationsManagement lowered new U.S. pumpers to flat-to-slightly down from up, indicating challenges in growth expectations.
Revenue And GuidanceTandem missed Q2 revenue estimates, including US pump revenue, and the company’s reduced FY25 guidance reflects this.
Stock ValuationThe stock is trading at its 3-year low, reaching a level where there is caution of seller exhaustion.
Tandem Diabetes Care News
TNDM FAQ
What was Tandem Diabetes Care’s price range in the past 12 months?
Tandem Diabetes Care lowest stock price was $9.98 and its highest was $38.28 in the past 12 months.
What is Tandem Diabetes Care’s market cap?
Tandem Diabetes Care’s market cap is $1.03B.
When is Tandem Diabetes Care’s upcoming earnings report date?
Tandem Diabetes Care’s upcoming earnings report date is Nov 06, 2025 which is today.
How were Tandem Diabetes Care’s earnings last quarter?
Tandem Diabetes Care released its earnings results on Aug 06, 2025. The company reported -$0.482 earnings per share for the quarter, missing the consensus estimate of -$0.399 by -$0.083.
Is Tandem Diabetes Care overvalued?
According to Wall Street analysts Tandem Diabetes Care’s price is currently Undervalued.
Does Tandem Diabetes Care pay dividends?
Tandem Diabetes Care does not currently pay dividends.
What is Tandem Diabetes Care’s EPS estimate?
Tandem Diabetes Care’s EPS estimate is -0.33.
How many shares outstanding does Tandem Diabetes Care have?
Tandem Diabetes Care has 67,569,470 shares outstanding.
What happened to Tandem Diabetes Care’s price movement after its last earnings report?
Tandem Diabetes Care reported an EPS of -$0.482 in its last earnings report, missing expectations of -$0.399. Following the earnings report the stock price went down -19.944%.
Which hedge fund is a major shareholder of Tandem Diabetes Care?
Currently, no hedge funds are holding shares in TNDM
Tandem Diabetes Care Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.95 (24.59% Upside)
$18.95 (24.59% Upside)
Blogger Sentiment
Neutral
TNDM Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 107.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $251.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.8%
Last 30 Days ▲ 4.4%
Last 30 Days ▲ 4.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.69%
12-Months-Change
Fundamentals
Return on Equity
-111.91%
Trailing 12-Months
Asset Growth
-6.59%
Trailing 12-Months
Company Description
Tandem Diabetes Care
Tandem Diabetes Care, Inc. is a medical device company focused on the design, development, and commercialization of innovative insulin delivery systems for people with diabetes. Headquartered in San Diego, California, Tandem specializes in advanced diabetes management technologies, primarily offering products such as the t:slim X2 insulin pump and the t:connect mobile app. The company aims to improve the lives of diabetes patients through cutting-edge technology, user-friendly designs, and integrated solutions that enhance insulin delivery and glucose management.
TNDM Company Deck
TNDM Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call showcased Tandem Diabetes Care's strong performance with record sales and significant progress in pharmacy channel expansion and international markets. However, there are challenges such as moderate U.S. sales growth and increased competition affecting the future outlook.View all TNDM earnings summariesTNDM Revenue Breakdown
74.21% U.S.
25.79% International
TNDM Stock 12 Month Forecast
Average Price Target
$18.95
▲(24.59% Upside)
Technical Analysis
Ownership Overview
0.98% Insiders
28.98% Mutual Funds
0.08% Other Institutional Investors
45.67% Public Companies and
Individual Investors